Trademarkia Logo

Canada

C$
Trademark Search in Canada
INNOVENT CHINESE CHARACTERS & DESIGN

View On IC.GC.CA

INNOVENT CHINESE CHARACTERS & DESIGN
REGISTERED

on 9 Mar 2021

Last Applicant/ Owned by

INNOVENT BIOLOGICS (SUZHOU) CO. LTD.

No. 168, Dongping Street, Suzhou Industrial Park215123 Suzhou City

CN

Serial Number

1928394 filed on 1st Nov 2018

Registration Number

TMA1095231 registered on 9th Mar 2021

Registration expiry Date

9th Mar 2031

Correspondent Address

NELLIGAN O'BRIEN PAYNE LLP

300-50 O'CONNOR STREETOTTAWA

ONTARIO

CA

K1P6L2

INNOVENT CHINESE CHARACTERS & DESIGN

Trademark usage description

medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disord Read More

Vienna Information

1 . 7 . 19

Several crescents or half-moonsPlusieurs croissants ou demi-lunes

1 . 15 . 23

Vortices, rotary movements, tornadoes -- Note: Not including astronomic orbits (1.13.1), atomic orbits (1.13.1), concentric circles (26.1.4 or 26.1.5) and spirals (26.1.5).Tourbillons, mouvements rotatifs, tornade -- Note: Non compris les orbites astronomiques (1.13.1), les orbites atomiques (1.13.1), les cercles concentriques (26.1.4 ou 26.1.5) et les spirales (26.1.5).

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

28 . 3 . 0

Inscriptions in Chinese, Japanese or Korean charactersInscriptions en caractères chinois, japonais ou coréens

Classification Information

Class [005]
Medicines for human purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; pharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; drugs for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; chemicopharmaceutical preparations, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; chemical preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; injectable preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; biological preparations for medical purposes, used for treating tumor, ophthalmology diseases, cardiovascular diseases, immune diseases, metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, blood diseases, diabetes, endocrine system diseases, namely growth and thyroid disorders, reproductive system diseases, respiratory system diseases, central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease, peripheral nervous system diseases and disorders, namely, convulsions and seizures, genetic diseases, and for anti-virus; human vaccines and vaccine adjuvants; diagnostic biomarker reagents for medical purposes and diagnostic reagents for medical diagnostic use; dietetic substances consisting of vitamins, minerals, amino acids and trace elements; biological preparations extracted from blood for medical use; biological tissue cultures for medical purposes; intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations

Classification kind code

11

Mark Details

Serial Number

1928394

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 18th Nov 2020		Advertised
Submitted for opposition 27
on 23rd Oct 2020		Approval Notice Sent
Submitted for opposition 26
on 23rd Oct 2020		Approved
Submitted for opposition 12
on 8th Jul 2020		Extension of Time
Submitted for opposition 12
on 13th Aug 2019		Extension of Time
Submitted for opposition 22
on 16th Jan 2019		Search Recorded
Submitted for opposition 20
on 16th Jan 2019		Examiner's First Report
Submitted for opposition 31
on 5th Nov 2018		Formalized
Submitted for opposition 1
on 2th Nov 2018		Created
Submitted for opposition 30
on 1st Nov 2018		Filed